The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Merrimack; MolecularMatch; Oculose, LLC; Roche; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex
 
Shannon L McDonough
No Relationships to Disclose
 
Van Karlyle Morris
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Anthony Martin Magliocco
No Relationships to Disclose
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Bayer; Genentech
Research Funding - GlaxoSmithKline; Merck; Novartis
 
Luis A. Diaz
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - PapGene, Inc.; Personal Genome Diagnostics
Consulting or Advisory Role - Genentech; Merck; Personal Genome Diagnostics
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - PapGene, PGDx and other entities have licensed several patent applications from Johns Hopkins, where Dr. Diaz is an inventor. These relationships are subject to certain restrictions under Johns Hopkins University policy, and the terms of these arrangement
Travel, Accommodations, Expenses - Merck
 
Carmen Joseph Allegra
Honoraria - Bristol-Myers Squibb (I)
 
Stephen E. Wang
No Relationships to Disclose
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Merck; Merrimack
 
S. Gail Eckhardt
Consulting or Advisory Role - CASI Pharmaceuticals; Champions Biotechnology; Kyowa Hakko Kirin; Lilly/ImClone; OnKure; Pfizer; Sanofi; Suvica; Taiho Pharmaceutical
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); cleave biosciences (Inst); Genentech (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
 
Thomas John Semrad
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genentech; Genzyme (I); Onyx
Research Funding - Astex Pharmaceuticals (Inst); Eisai (Inst); Genentech (Inst); Millennium (Inst); Morphotek (Inst); Novartis (Inst)
 
Kimberly Kaberle
No Relationships to Disclose
 
Katherine A Guthrie
No Relationships to Disclose
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical